Government official: Coronavirus vaccine trial begins Monday | FOX 4 Kansas City WDAF-TV
This is an archived article and the information in the article may be out of date. Please look at the history’s timestamp to see when it was last updated.
WASHINGTON (AP) – A clinical trial evaluating a vaccine designed to protect against the new coronavirus will begin on Monday, according to a government official.
The first participant in the trial will receive the experimental vaccine on Monday, the official said, speaking on condition of anonymity because the trial has not yet been publicly announced. The National Institutes of Health is funding the trial, which is taking place at the Kaiser Permanente Washington Health Research Institute in Seattle, the official said.
Public health officials say it will take a year to 18 months to fully validate any potential vaccine.
Testing will begin with 45 healthy young volunteers with different doses of vaccines co-developed by NIH and Moderna Inc. There is no chance that participants will be infected with the vaccines, as they do not contain the virus itself. same. The aim is purely to verify that the vaccines do not present worrisome side effects, thus paving the way for more important tests.
Dozens of research groups around the world are rushing to create a vaccine as cases of COVID-19 continue to rise. Above all, they are looking for different types of vaccines – injections developed from new technologies that are not only faster to produce than traditional inoculations, but could turn out to be more potent. Some researchers are even targeting temporary vaccines, such as injections that could protect people’s health for a month or two at a time while more lasting protection is developed.
For most people, the new coronavirus causes only mild or moderate symptoms, such as fever and cough. For some, especially the elderly and people with existing health problems, it can cause more serious illness, including pneumonia. The global epidemic has sickened more than 156,000 people and killed more than 5,800. The death toll in the United States is more than 50, while infections have approached 3,000 in 49 states and the District of Columbia.
The vast majority of people recover. According to the World Health Organization, people with mild illness recover in about two weeks, while those with more severe illness can take three to six weeks to recover.
Suggest a correction